10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001248915-14-000136`
Period End Date	20140630
Filing Date	20140811
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	spzr-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 45 Income Statement 28 Cash Flow Statement 28

Balance Sheet 45 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.43K	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.79K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$12.01K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$4.47K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total Assets	`Assets`	$4.47K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total Assets	`Assets`	$12.01K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	15.41M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	12.14M	shares	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$2.00K	USD	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$22.70K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	12.14M	shares	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	15.41M	shares	Point-in-time
Loans from Stockholders	`DueToOfficersOrStockholdersCurrent`	$2.00K	USD	Point-in-time
Loans from Stockholders	`DueToOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$24.70K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.00K	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 15,409,999 and 12,142,025 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$121.42K	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 15,409,999 and 12,142,025 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$121.42K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.30M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.39M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.41M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$10.00K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-20.23K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$12.01K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$4.47K	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
General and Administrative	`GeneralAndAdministrativeExpense`	$19.30K	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$11.72K	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$3.89K	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$8.59K	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-3.89K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-8.59K	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-11.72K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-19.30K	USD	2 Qtrs
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.59K	USD	2 Qtrs
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-11.72K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-19.30K	USD	2 Qtrs
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.89K	USD	1 Quarter
Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income Taxes	`IncomeTaxExpenseBenefit`	$467.00	USD	2 Qtrs
Income Taxes	`IncomeTaxExpenseBenefit`	$185.00	USD	1 Quarter
Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-11.90K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-8.59K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-3.89K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-19.77K	USD	2 Qtrs
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.16M	shares	2 Qtrs
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	15.41M	shares	1 Quarter
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	2 Qtrs
Weighted Average Shares Outstanding - Basic and Diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	1 Quarter

Cash Flow Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-11.90K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-8.59K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-3.89K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-19.77K	USD	2 Qtrs
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-20.69K	USD	2 Qtrs
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-7.36K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.95K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-40.46K	USD	2 Qtrs
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Issuance of Common Stock	`ProceedsFromIssuanceOfCommonStock`	$50.00K	USD	2 Qtrs
Loans from Stockholders	`ProceedsFromRelatedPartyDebt`	$-2.00K	USD	2 Qtrs
Loans from Stockholders	`ProceedsFromRelatedPartyDebt`	$17.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$17.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$48.00K	USD	2 Qtrs
Increase (decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.05K	USD	2 Qtrs
Increase (decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$7.54K	USD	2 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$2.43K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$7.79K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$2.43K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$249.00	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$7.79K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	2 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income Taxes	`IncomeTaxesPaid`	$467.00	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.